These mutations increase YAP stability in the cytoplasm, enabling its transcriptional activation of glycolytic genes, including GLUT3 (glucose transporter 3), which enhances the invasiveness and stemness of CRC cells (54). Here, YAP1 is linked to colorectal carcinoma.